Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GLS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Analysts have been raising forward EPS estimates
High and improving ROE
High and improving operating margin
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
GLS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GLS Bulk, Block & Insider Trades
GLS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range o... Read More
Key personnel
Mr. Hiren Karsanbhai PatelD
Non-Executive Non-Independent Chairman of the Board
Dr. Yasir Yusufali RawjeeD
Chief Executive Officer, Managing Director, Executive Director
Mr. Tushar Mistry
Chief Financial Officer, Senior Vice President
Mr. Sumantra Mitra
Senior Vice President - Human Resources, Head - Human Resources
Mr. Navin Kumar Agrawal
Senior Vice President - Quality, Head - Corporate Quality
Mr. Mathew George
Senior Vice President - Regulatory Affairs, Head - Regulatory Affairs
Mr. Rudalf Joseph Corriea
Company Secretary, Compliance Officer
Dr. Palle V.R Acharyulu
Group Vice President, Head - Research and Development
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Alivus Life Sciences Ltd.?
The current share price of Alivus Life Sciences Ltd. is ₹ 879.75 as of 09 Jan 2026.
What is the PE ratio of Alivus Life Sciences Ltd.?
The Price-to-Earnings (PE) ratio of Alivus Life Sciences Ltd. is 20.35 as of the latest financial data.
What is the ROE and ROCE of Alivus Life Sciences Ltd.?
Alivus Life Sciences Ltd. has a Return on Equity (ROE) of 19.10% and a Return on Capital Employed (ROCE) of 23.93% as per the latest financial reports.
What is the market cap of Alivus Life Sciences Ltd.?
The market capitalization of Alivus Life Sciences Ltd. stands at ₹ 10,792.90 Cr.
What is the dividend yield of Alivus Life Sciences Ltd.?
The dividend yield of Alivus Life Sciences Ltd. is 0.57% based on the current market price.
What is the RSI of Alivus Life Sciences Ltd.?
The Relative Strength Index (RSI) of Alivus Life Sciences Ltd. is 42.22.
What is the FII and DII holding in Alivus Life Sciences Ltd.?
Foreign Institutional Investors (FII) hold 6.84% and Domestic Institutional Investors (DII) hold 4.11% of Alivus Life Sciences Ltd. shares.
What sector does Alivus Life Sciences Ltd. belong to?
Alivus Life Sciences Ltd. operates in the Healthcare sector.
What is the beta of Alivus Life Sciences Ltd. stock?
The beta of Alivus Life Sciences Ltd. stock is 0.93, indicating its volatility relative to the broader market.
